Rodriguez-Rodriguez, AnaEgea-Guerrero, Juan Jose2023-01-252023-01-252016-11-18Rodríguez-Rodríguez A, Egea-Guerrero JJ. The utility of biomarkers in traumatic brain injury clinical management. Crit Care. 2016 Nov 18;20(1):376.http://hdl.handle.net/10668/10612We read the article by Thelin et al. entitled “Utility of neuron-specific enolase in traumatic brain injury; relations to S100B levels, outcome, and extracranial injury severity” [1] with great interest. The authors conclude that while S100B and neuron-specific enolase (NSE) are both biomarkers for long-term outcome, S100B is a more accurate predictor.enAttribution 4.0 Internationalhttp://creativecommons.org/licenses/by/4.0/Traumatic brain injuryBiomarkersNeuron-specific enolaseS100B proteinPrognosisExtracranial injuryBiomarkersBrain Injuries, TraumaticHumansletter27855696open accessTraumatismo craneoencefálicoBiomarcadores biológicosEnolasa específica de neuronasProteína S100BPronósticoLesiones extracraneales10.1186/s13054-016-1545-51466-609XPMC5114747https://doi.org/10.1186/s13054-016-1545-5https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5114747/pdf